Atlas Trials

A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose

Clinical trial NCT03250182 · COMPLETED

Trial details

NCT number
NCT03250182
Sponsor
Pearl Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2017-08-11
Primary completion
2017-12-07
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.